Literature DB >> 24687662

COPD assessment: I, II, III, IV and/or A, B, C, D.

Claus Vogelmeier1, Jørgen Vestbo.   

Abstract

Mesh：

Year:  2014        PMID： 24687662     DOI： 10.1183/09031936.00019714

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  3 in total

1.  Bioactive lipids in emphysema. Decoding fat to reveal COPD phenotypes.

Authors:  Mehdi Mirzaie; Farrah Kheradmand
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

Review 2.  Chronic Obstructive Pulmonary Disease heterogeneity: challenges for health risk assessment, stratification and management.

Authors:  Josep Roca; Claudia Vargas; Isaac Cano; Vitaly Selivanov; Esther Barreiro; Dieter Maier; Francesco Falciani; Peter Wagner; Marta Cascante; Judith Garcia-Aymerich; Susana Kalko; Igor De Mas; Jesper Tegnér; Joan Escarrabill; Alvar Agustí; David Gomez-Cabrero
Journal:  J Transl Med       Date:  2014-11-28       Impact factor: 5.531

3.  From comorbidities of chronic obstructive pulmonary disease to identification of shared molecular mechanisms by data integration.

Authors:  David Gomez-Cabrero; Jörg Menche; Claudia Vargas; Isaac Cano; Dieter Maier; Albert-László Barabási; Jesper Tegnér; Josep Roca
Journal:  BMC Bioinformatics       Date:  2016-11-22       Impact factor: 3.169
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.